Pharmacy's Rising Role in Cell and Gene Therapy: Zahra Mamoudjafari, PharmD, MBA
Cell and gene therapies (CGTs) are receiving approvals faster than health‑care institutions can operationalize them. Zahra Mahmoudjafari, a clinical pharmacy leader at the University of Kansas Health System, published a framework outlining eight interdependent domains needed for financially sustainable, patient‑accessible CGT programs. She warns that most programs are built reactively after approval, which creates bottlenecks in financing, reimbursement, and patient access. The framework stresses proactive infrastructure and pharmacy’s expanding role across oncology and gene‑therapy workflows.
Helpful Webinars and Other Resources for Generic Drug Manufacturers
The FDA has compiled a suite of webinars, workshops and seminars aimed at helping generic drug manufacturers improve their abbreviated new drug application (ANDA) submissions. Topics span bioequivalence studies, inactive ingredient databases, sample retention, and product‑specific challenges for oral, inhalation,...
About the Quantitative Medicine Center of Excellence (QM CoE)
The FDA’s Center for Drug Evaluation and Research (CDER) has launched the Quantitative Medicine Center of Excellence (QM CoE) to centralize quantitative expertise across its offices. Governance includes senior leaders from the Offices of Generic Drugs, New Drugs, Pharmaceutical Quality,...
FDA Clears Next-Gen Device for Left-Heart Access
Protaryx Medical received FDA clearance for its next‑generation Transseptal Puncture Device, enabling left‑heart access in minimally invasive cardiac procedures. The system features zero‑exchange delivery, an atraumatic design, an echogenic extendable probe and a standardized RF guidewire compatible with multiple electrosurgical...
Cancer Dependency Map Consortium Launches Phase 3 to Accelerate Next-Generation Therapeutics
The Broad Institute’s Cancer Dependency Map Consortium (DMC) has entered Phase 3, expanding its mission beyond cataloguing tumor vulnerabilities to tackling drug resistance, surface‑protein targets, and high‑dimensional readouts. Backed by 23 pharma partners, the consortium builds on DMC 2.0’s expansion to over...
Elahere Combination Achieves 62.7% ORR in Phase 2 Trial for Platinum-Sensitive Ovarian Cancer at SGO 2026
AbbVie’s Elahere (mirvetuximab soravtansine) combined with carboplatin produced a confirmed objective response rate of 62.7% in patients with FRα‑positive, platinum‑sensitive ovarian cancer, meeting the primary endpoint of the Phase 2 IMGN853‑0420 trial presented at SGO 2026. The study enrolled 125 participants,...
Enhancement of Intestinal Barrier Function and Alleviation of Mycophenolic Acid Toxicity by a Probiotic-Conditioned Medium in Vitro
The study demonstrates that an acellular probiotic‑conditioned medium (postbiotic) strengthens intestinal barrier function and mitigates toxicity of the immunosuppressants mycophenolic acid (MPA) and mycophenolate mofetil (MMF) in a CaCo‑2 cell model. The conditioned medium increased transepithelial electrical resistance, up‑regulated tight‑junction...
Regulation of Bile Acids Homeostasis: A Feasible and Versatile Way to Treat or Diagnose Liver Disorders
The review underscores bile‑acid (BA) homeostasis as a central driver of liver disease, linking imbalances to cholestasis, fibrosis, cirrhosis, hepatocellular carcinoma and MASLD/MASH. It details how hydrophobic BAs provoke mitochondrial and endoplasmic reticulum stress, activate hepatic stellate cells, and interact...
A Built-In 'Hairpin' Prevents Rogue CRISPR RNAs
Researchers at the Helmholtz Institute for RNA‑based Infection Research have identified a conserved RNA hairpin that blocks the production of extraneous CRISPR RNAs (ecrRNAs) in diverse CRISPR‑Cas13 systems. The hairpin binds the first repeat in the CRISPR array, preventing Cas13...
Physics‑Based Sensors and AI Transform Bioreactor Monitoring
Bioreactors are billion-dollar processes monitored by pH probes and dissolved oxygen sensors. That's like running a semiconductor fab with a thermometer. @schmidtsciences is adapting physics tools that don't usually touch biology: fluorescent nanodiamonds, single-cell Raman spectroscopy, and optical frequency combs that...
GLP-1 Drug Improves Liver Health Independent of Weight Loss, Mouse Study Finds
Researchers at Toronto’s Sinai Health discovered that semaglutide, a GLP‑1 agonist, improves liver function by acting directly on liver sinusoidal endothelial cells, independent of weight loss. The study, published in Cell Metabolism, used mouse models of metabolic dysfunction‑associated steatohepatitis (MASH)...
Targeting Aging: Epigenetic Reprogramming Tackles Disease Root
Aging is arguably the root cause of most major diseases. Our cells lose function as we age, allowing various conditions to manifest, which is why most major diseases correlate with age. Yes, it is more complex than this, but this is...
Low‑cost Vaccines Bypass Big Pharma, Influencers Profit
No, the opposite. I develop low cost vaccines that bypass big pharma. The only shills are those connected to the corrupt wellness influencer industry, which buys whatever it can in bulk cheap so they can jack up the price with...
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
AbbVie signed an exclusive licensing deal with China’s Haisco Pharmaceutical to develop, manufacture and sell a suite of novel pain compounds outside mainland China, Hong Kong and Macau. The agreement provides Haisco $30 million upfront and up to $715 million in milestone payments,...
FDA Bolsters Bespoke Therapy Framework with New Draft Safety Guidelines
The FDA’s Center for Biologics Evaluation and Research issued draft guidance to standardize safety assessments for genome‑editing therapies, covering both ex vivo and in vivo products that use next‑generation sequencing to detect off‑target effects. The recommendations target nonclinical studies supporting IND and...
New Alzheimer’s Blood Test Promises Earlier Detection
Researchers at Mass General Brigham have shown that the blood‑based pTau217 biomarker can predict amyloid and tau plaque buildup years before PET scans turn positive, even in asymptomatic adults aged 50 to 90. The study of 317 participants demonstrated that...
Nasal EV Spray Reverses Neuroinflammation and Boosts Memory
A nasal spray delivering extracellular vesicles reversed neuroinflammation, restored mitochondrial function, and improved memory in aging brain models, suggesting a noninvasive approach to counteract cognitive decline. neuroscience
Apple Studio Display XDR Now Cleared for Diagnostic Radiology
Apple’s Studio Display XDR has received FDA clearance for diagnostic radiology, allowing U.S. radiologists to view medical images on the consumer‑grade monitor. The display supports DICOM presets on macOS 26.4, eliminating the need for dedicated imaging screens. Priced at $2,899,...
MIC11 Deletion Traps Parasites, Reveals Escape Target
Removal of the MIC11 gene traps parasites inside host cells by blocking membrane rupture, highlighting a critical mechanism required for their escape and suggesting a potential target for controlling parasite-borne diseases. parasitology
Fordham 33 (Report 4): Life Sciences and Healthcare Innovation
A multinational panel at Fordham’s IPKat event dissected life‑science patent strategies across the U.S., Europe, Japan and the upcoming Unified Patent Court. Speakers highlighted how European protocol disclosures reveal methods but not results, making anticipatory rejections rare, while U.S. product‑for‑use...
Reproxalap Safe for Use in Patients With Dry Eye Disease
A Phase 3 trial of 0.25 % reproxalap eye drops in 757 dry‑eye disease patients found no serious treatment‑related adverse events. Mild ocular irritation was the most common side effect, occurring more often in older women. Visual acuity showed modest improvement, especially...
AWS Launches Amazon Bio Discovery for AI-Powered Scientific Experimentation
Amazon Web Services unveiled Amazon Bio Discovery, a cloud‑based platform that supplies scientists with a curated library of biological foundation models (bioFMs) for generating and evaluating drug molecules. The service lets researchers train custom models on their own experimental data...
Updated: FDA Asks for Data on Lilly’s Foundayo to Assess Heart, Liver Risks
The U.S. Food and Drug Administration has asked Eli Lilly for additional safety data on its newly approved obesity medication, Foundayo. The agency is specifically seeking information on any cardiovascular events and liver‑related adverse effects observed in clinical trials and post‑marketing...
Replimune Looks Ahead as Repeat CRL Speeds the Company's Decline
Replimune received a second complete response letter (CRL) from the FDA for its lead oncolytic cancer therapy, citing additional data gaps and manufacturing concerns. The regulatory setback triggered a wave of layoffs affecting roughly 30% of its workforce and pushed...
Two Previously Unreported Prostate Cancer Gene Candidates Identified Through Governed Multi-Omics Screening of TCGA-PRAD
A governed multi‑omics screening pipeline applied to the TCGA‑PRAD cohort filtered 19,010 genes through four independent quality gates, identifying 942 high‑confidence candidates. Ten matched known prostate cancer genes, confirming sensitivity, while two novel candidates—DNAH5 and PRR36—showed strong over‑expression and statistical...
Max Hodak’s Science Corp. Is Preparing to Place Its First Sensor in a Human Brain
Science Corp, the neurotechnology startup founded by former Neuralink president Max Hodak, has recruited Yale neurobiologist Murat Günel as a scientific adviser to oversee its first U.S. human trials of a bio‑hybrid brain‑computer interface. The company recently closed a $230 million Series C...
Novo Nordisk, OpenAI Bring AI Into Core Operations to Accelerate Time to Market
Novo Nordisk has teamed up with OpenAI to embed advanced artificial intelligence across its entire value chain, from early‑stage research to manufacturing, distribution, and commercial operations. The partnership aims to accelerate drug discovery, streamline production, and shorten the time it...
Genetically Switched Microbes Aim to Cut Synthetic Nitrogen Use
Nitrogen fertilizer feeds 4 billion people. It also uses 2% of global energy to produce and loses nearly half of what's applied to runoff. Biology has promised a fix for decades. The problem: engineered microbes that make nitrogen can't also compete...
RBM20 Genetic Variants Linked to Arrhythmogenic Dilated Cardiomyopathy
A large cohort study using UK Biobank, All of Us, and an international registry shows that RBM20 gene variants contribute to arrhythmogenic dilated cardiomyopathy (DCM). While pathogenic missense RBM20 variants are linked to severe disease, truncating RBM20 variants present later...
NEW STUDY: Frog-Derived Gut Bacterium Completely Eradicates 100% of Tumors After a Single Dose in Mice
A peer‑reviewed study in *Gut Microbes* reports that a single intravenous dose of the frog‑derived gut bacterium Ewingella americana eradicated colorectal tumors in 100% of immunocompetent mice. The live microbe outperformed both doxorubicin chemotherapy and anti‑PD‑L1 checkpoint blockade, achieving complete...
Shawn Davis, MD, on Access, Coverage, and the Future of Obesity Therapy
The FDA’s approval of oral semaglutide (Rybelsus) was hailed as a breakthrough for obesity treatment, yet uptake has lagged as patients on injectable GLP‑1s show little interest in switching to a daily pill. Early market confusion stemmed from the drug’s...
Guardian Analysis Debunks Claim that Diverse Gut Microbiome Guarantees Immunity
A new Guardian analysis refutes the popular biohacker belief that a diverse gut microbiome prevents disease, citing recent research that highlights competition among microbes as the key factor. The piece urges caution toward commercial products promising microbiome “fixes.”
Neuralink Shifts to Speech‑Focused Brain‑Computer Interface Trials, Raising Viability Questions
Neuralink announced new speech‑restoration clinical trials at the University of Texas Southwestern Medical Center and Cleveland Clinic Abu Dhabi, moving away from its long‑standing motor‑cursor interface. The pivot follows criticism that its original brain‑computer interface (BCI) strategy lags behind competitors...
FDA Grants Full Approval to Travere’s FILSPARI for FSGS, Unlocking $2B Market
Travere Therapeutics announced that the FDA has granted full approval to FILSPARI (sparsentan) for focal segmental glomerulosclerosis (FSGS) without nephrotic syndrome. The decision makes FILSPARI the first approved therapy for the rare kidney disease and expands the drug’s addressable U.S....
In the Clinic for April 14, 2026
The "In the clinic for April 14, 2026" page serves as a centralized hub that aggregates the latest Bioworld data snapshots, special reports, and infographics across biopharma, medical technology, and emerging therapeutic areas. It links to analyses on mRNA vaccine...
Breast Milk’s Living Stem Cells May Reach Infant Brain
Breast milk contains living stem cells. In animal studies, these cells survived digestion in newborns, entered the bloodstream, and were found in multiple tissues including the brain. Whether this happens in humans is still being studied, but the animal data...
New CellCelector CLD Takes You From Thousands of Candidates to the Top Clone, Faster
German biotech equipment maker Sartorius has launched the CellCelector CLD, an automated imaging and cell isolation platform that accelerates monoclonal cell line development. The system combines high‑speed scanning, advanced imaging and gentle clone retrieval to screen up to 885 nanowell...
BHV-2100
Researchers from KU Leuven, CISTIM Leuven and Biohaven Therapeutics have announced that an oral TRPM3 antagonist has entered Phase 2 clinical testing for the acute treatment of migraine. The program leveraged a cell‑based high‑throughput screen of more than 200,000 compounds to...
50 Employees Impacted as Astellas Closes Universal Cells' Seattle Office
Tokyo‑based Astellas Pharma announced the closure of Universal Cells' Seattle office, affecting 50 employees. A handful of staff will be transferred to Astellas’ research sites in South San Francisco and Westborough, while the remainder face layoffs in waves from July...
Continuous Fermentation Cuts Costs, Beats Traditional Bioreactors
The biomanufacturing bottleneck isn't biology. It's economics. Building bigger bioreactors doesn't fix unit costs. https://t.co/2RAcw704uk's bet: continuous fermentation decouples growth from production, keeps cells in an ultra-productive state for weeks, and runs like a conveyor belt instead of a batch process. ...
High Blood Glucose Linked to Cognitive Decline via Lactate Pathway
How do high glucose levels in the blood impair cognition and predict mild cognitive impairment in people with diabetes? @scisignal Elevated plasma lactate and related pathway, with a peptide intervention to potentially address it https://t.co/ai1369HWVU https://t.co/JcszZT2Tt2
Endpoints Biopharma Sentiment Survey for Q2 2026
Endpoints Signal is launching its Q2 2026 Biopharma Sentiment Index (BPSI) survey, a three‑minute questionnaire that aggregates insider views into a quarterly benchmark. More than 1,000 biopharma professionals participated in the previous quarter, providing a snapshot of sentiment on pipelines, pricing...
GLP‑1 Drugs Show Weight‑loss‑independent Benefits, Study Finds
Great work by @DanielJDrucker and team; biologically plausible mechanism of GLP1-RA benefit independent of weight loss. Excellent article by @megtirrell @CNN describing the publication. Could it justify new approaches for these drugs? I think so. https://t.co/pHudk7lkAR
Bots Code My Tools While I Hit the Wetlab
Launching bots to code my science tools while I go do wetlab work feels like this track: https://t.co/xxRAzKXQ4x
J&J Increasingly Confident It Can Manage Stelara Cliff, but Work Remains
Johnson & Johnson says the most intense biosimilar pressure on its blockbuster drug Stelara is largely behind it, and the company now projects robust growth through the late 2020s. Executives cite new therapeutic indications, expanded global reach, and strategic pricing...
Comprehensive Genomic Panel Broadens Oncology Treatment Options
Unique Features of a Comprehensive Genomic Profiling Panel: Expanding Treatment Options in a Value-Based Community Oncology Network [Mar 9, 2026] La Porte et al. @DrEzraCohen @JCOPO_ASCO https://t.co/tDi3kbxdvX #PrecisionMedicine #hemeonc @TempusAI https://t.co/zgEw8hfFia
Real-World Data Reveal Molecular Profile of Metastatic ILC
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI https://t.co/oDkC1Ua6DS
PurIST Classifier Validated for Pancreatic Cancer Therapy
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection [PurIST @TempusAI] in Pancreatic Ductal Adenocarcinoma [Sep 4, 2025] @stephwen et al. @JCOPO_ASCO https://t.co/R24DErvaB4 #pancsm #PrecisionMedicine https://t.co/40LqNDQJHo
Somatic Immune Cell Mutations Linked to Autoimmunity
New evidence that somatic mutations in immune cells can be the basis for autoimmune disease @Nature https://t.co/GvzxLYgvfw
RUNX1 Identified as Key to Rejuvenate Aging T Cells
Discovery of a factor (RUNX1) that pinpoints T cell senescence and restoring its functionality achieves T cell rejuvenation. Significant implications in older adults with loss of immune system protection. https://t.co/X58DvzIUXY @ImmunityCP https://t.co/hzL3zFiPMm